BDBM50312656 1-{N-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-(2-[2,4-difluorophenyl]ethylamino)pyrazinone::CHEMBL1083189
SMILES: [#6]-c1cnc(-[#7]-[#6]-[#6]-c2ccc(F)cc2F)c(=O)n1-[#6]-[#6](=O)-[#7]-[#6]-[#6]-[#8]\[#7]=[#6](\[#7])-[#7]
InChI Key: InChIKey=RTFHPZIOEZHLGC-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prothrombin (Homo sapiens (Human)) | BDBM50312656 (1-{N-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethy...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | 15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL | Assay Description Inhibition of human alpha-thrombin | J Med Chem 53: 1843-56 (2010) Article DOI: 10.1021/jm901802n BindingDB Entry DOI: 10.7270/Q22807Q9 | |||||||||||
More data for this Ligand-Target Pair |